Andrea Tu, Author at Bolt Biotherapeutics

About Andrea Tu

This author has yet to write their bio.
Meanwhile lets just say that we are proud Andrea Tu contributed a whooping 52 entries.

Entries by

Press Release

February 5, 2021 in press release /by Andrea Tu

Bolt Biotherapeutics Prices Upsized Initial Public Offering

Press Release

January 3, 2021 in press release /by Andrea Tu

Bolt Biotherapeutics Expands Board of Directors with Appointment of Kathleen LaPorte

Press Release

December 9, 2020 in press release /by Andrea Tu

Bolt Biotherapeutics Presents Ongoing Clinical Trial Poster at San Antonio Breast Cancer Symposium 2020 Virtual Meeting

Press Release

December 7, 2020 in press release /by Andrea Tu

Data Published in Nature Cancer Highlight Preclinical Proof of Concept of Bolt Biotherapeutics’ Boltbody™ ISAC Platform

Podcast

September 21, 2020 in podcast /by Andrea Tu

Dr. Randy Schatzman On Dodging Disruption: The New Fundraising Norm Business of Biotech Podcast

Press Release

September 20, 2020 in press release /by Andrea Tu

Bolt Biotherapeutics Presents BDC-1001 Ongoing Clinical Trial Design and Supportive Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting

Press Release

August 1, 2020 in press release /by Andrea Tu

Bolt Biotherapeutics Closes $93.5 Million Series C Financing

Podcast

July 22, 2020 in podcast /by Andrea Tu

CMC Considerations For In-Human Studies with Drs. Edith Perez and Nathan Ihle Business of Biotech Podcast

Podcast

July 21, 2020 in podcast /by Andrea Tu

Randy Schatzman, PhD, CEO of Bolt Biotherapeutics Biotech 2050 Podcast

Media Coverage

July 7, 2020 in media coverage /by Andrea Tu

Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs Xconomy